Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
Top Cited Papers
Open Access
- 1 April 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 14 (4), 327-334
- https://doi.org/10.1016/s1470-2045(13)70045-7
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735Molecular Cancer Therapeutics, 2012
- A novel retinoblastoma therapy from genomic and epigenetic analysesNature, 2012
- Loss of pRB causes centromere dysfunction and chromosomal instabilityGenes & Development, 2010
- Division and apoptosis of E2f-deficient retinal progenitorsNature, 2009
- Array comparative genomic hybridization in retinoma and retinoblastoma tissuesCancer Science, 2009
- Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expressionGenes, Chromosomes and Cancer, 2007
- Cytogenetically balanced translocations are associated with focal copy number alterationsHuman Genetics, 2006
- Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFHuman Mutation, 2004
- X‐Arrestin: a new retinal arrestin mapping to the X chromosomeFEBS Letters, 1993
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences of the United States of America, 1971